ATRA icon

Atara Biotherapeutics
ATRA

Overview Fund Activity

53 hedge funds and large institutions have $461M invested in Atara Biotherapeutics in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 8 reducing their positions, and 3 closing their positions.

Holders
53
Holders Change
+14
Holders Change %
+35.9%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
26
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BG
1
Baupost Group
Massachusetts
$193M
2
EC
2
EcoR1 Capital
California
$44.2M
3
Neuberger Berman Group
3
Neuberger Berman Group
New York
$18.6M
4
Jennison Associates
4
Jennison Associates
New York
$24.7M
5
EAM
5
EverPoint Asset Management
Connecticut
$10.5M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$28.8M
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
Norges Bank
3
Norges Bank
Norway
$1.04M
4
CSS
4
Cubist Systematic Strategies
Connecticut
$71K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$5.99M
Name Holding Trade Value Shares
Change 		Shares
Change %
IWM
51
Integrated Wealth Management
California
$2K +$2K +2 New
Bank of America
52
Bank of America
North Carolina
$1K +$1K +1 New
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$114 +$114 +110 New
Goldman Sachs
54
Goldman Sachs
New York
– -$1.41M -2,100 Closed
Susquehanna International Group
55
Susquehanna International Group
Pennsylvania
– -$246K -368 Closed
CFA
56
CT Financial Advisors
Pennsylvania
– -$10.7K -16 Closed
1 2
3